goralatide and Lung Neoplasms
goralatide has been researched along with Lung Neoplasms in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bignon, J; Fromes, Y; Katsoris, P; Kovacevic, M; Lallemand, JY; Lawrence, F; Liu, JM; Papadimitriou, E; Potier, P; Wdzieczak-Bakala, J | 1 |
Bogden, AE; Carde, P; de Paillette, ED; Frindel, E; Moreau, JP; Tubiana, M | 1 |
Other Studies
2 other study(ies) available for goralatide and Lung Neoplasms
Article | Year |
---|---|
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
Topics: Abdominal Wall; Adenocarcinoma; Allantois; Animals; Cell Differentiation; Cell Fusion; Cell Line, Transformed; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Collagen; Drug Combinations; Drug Implants; Endothelium, Vascular; Enzyme Activation; Enzyme Induction; Humans; Laminin; Lung Neoplasms; Matrix Metalloproteinase 1; Neovascularization, Physiologic; Oligopeptides; Proteoglycans; Rats; Rats, Wistar; Tumor Cells, Cultured; Umbilical Veins | 2003 |
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
Topics: Animals; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line; Cyclophosphamide; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunologic Deficiency Syndromes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Transplantation, Heterologous | 1991 |